This federal contract award is a delivery order, valued at $46,600.20, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty medication, to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.
Generated 2/25/25, 9:43 AM